Life ScienceCompany
Who owns Cymabay Therapeutics?
Cymabay Therapeutics is owned by Gilead Sciences. It was acquired in 2024.
Cymabay Therapeutics is owned by Gilead Sciences. It was acquired in 2024.
7575 Gateway Boulevard, Suite 110,
Newark, California
94560
United States,
(510) 293-8800
www.cymabay.com
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2024-02-12 | Gilead Sciences | |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
